Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

AMNEAL
FDA Approves Unknown Drug — AMNEAL

AMNEAL Pharmaceuticals announced the approval of their [Substance] abbreviated new drug application, a move that is projected to drive significant cos...

E.R.
FDA Approves OPDIVO QVANTIG — E.R. Squibb & Sons, L.L.C.

On December 27, 2024, the FDA approved **E.R. Squibb & Sons, L.L.C.**’s OPDIVO QVANTIG (nivolumab and hyaluronidase-nvhy), a novel subcutaneous formul...

AUROBINDO
FDA Approves Unknown Drug — AUROBINDO PHARMA LTD

# FDA Approves Generic Drug Application for Aurobindo Pharma Aurobindo Pharma Ltd. received FDA approval for ANDA215971 on December 26, 2024, expandi...

Ionis
FDA Approves TRYNGOLZA — Ionis Pharmaceuticals, Inc.

On December 19, 2024, Ionis Pharmaceuticals received FDA approval for TRYNGOLZA (olezarsen sodium), a novel subcutaneous product addressing an unmet n...

GRANULES
FDA Approves Unknown Drug — GRANULES

Grex, Inc. (GRANULES) received approval on December 16, 2024, for its Abbreviated New Drug Application (ANDA219258), unleashing significant pricing pr...

CHECKPOINT
FDA Approves Unknown Drug — CHECKPOINT THERAPEUTICS INC

Checkpoint Therapeutics Inc. announced FDA approval of its drug following the Dec. 13 notice, a development the company is positioning as a pivotal mo...

Merus
FDA Approves BIZENGRI — Merus US, Inc.

The FDA’s approval of Zenocutuzumab (Bizengri) on December 4 grants Merus US, Inc. commercial rights to a first-in-class therapy for NRG1 fusion-posit...

Biocon
FDA Approves YESINTEK — Biocon Biologics Inc.

Biocon Biologics Inc. announced the FDA approval of YESINTEK (ustekinumab) for the treatment of moderate-to-severe plaque psoriasis, a strategic expan...

Jazz
FDA Approves ZIIHERA — Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals announced on Friday the FDA approval of ZIIHERA (zanidatamab) for heavily pretreated gastroesophageal junction and HER2-positive ...

Amneal
FDA Approves EXENATIDE — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals LLC has received FDA approval for its ANDA for exenatide injection, setting the stage for increased market competition in the d...

Wuxi
FDA Approves MYCOPHENOLATE MOFETIL — Wuxi Fortune Pharmaceutical Co.,Ltd.

Wuxi Fortune Pharmaceutical has secured FDA approval for its generic Mycophenolate Mofetil (ANDA 214079), signals an escalation in its U.S. market pre...

Azurity
FDA Approves DANZITEN — Azurity Pharmaceuticals, Inc.

On November 7, 2024, Azurity Pharmaceuticals received FDA approval for Danziten (nilotinib), expanding access to this oral therapy amid a competitive ...

Camber
FDA Approves MYCOPHENOLATE MOFETIL — Camber Pharmaceuticals, Inc.

Camber Pharmaceuticals announced today that the FDA has approved ANDA 207022 for Mycophenolate Mofetil, marking a new entry into the market for the im...

Camber
FDA Approves MYCOPHENOLATE MOFETIL — Camber Pharmaceuticals, Inc.

FDA granted approval today to Camber Pharmaceuticals for Mycophenolate Mofetil oral tablets, expanding its 2 mg strength to a 500 mg dosage in respons...

UBI
FDA Approves LEUPROLIDE ACETATE — UBI Pharma Inc.

# FDA Approves UBI Pharma's Generic Leuprolide Acetate Injection The FDA has approved UBI Pharma Inc.'s abbreviated new drug application (ANDA) for l...

AbbVie
FDA Approves VYALEV — AbbVie Inc.

# FDA Approves AbbVie's VYALEV for Parkinson's Disease Treatment AbbVie Inc. received FDA approval for VYALEV (foscarbidopa/foslevodopa) subcutaneous...

Pfizer
FDA Approves HYMPAVZI — Pfizer Laboratories Div Pfizer Inc

# FDA Approves Pfizer's HYMPAVZI for Hemophilia A Treatment Pfizer has received FDA approval for HYMPAVZI (marstacimab-hncq), a subcutaneous therapy ...

Genentech,
FDA Approves ITOVEBI — Genentech, Inc.

# FDA Approves Genentech's ITOVEBI (inavolisib) for PIK3CA-Mutant Breast Cancer Genentech announced FDA approval of ITOVEBI (inavolisib), an oral PI3...

Amneal
FDA Approves PYRIDOSTIGMINE BROMIDE — Amneal Pharmaceuticals LLC

# FDA Approves Amneal Pharmaceuticals' Pyridostigmine Bromide Oral Formulation Amneal Pharmaceuticals LLC received FDA approval for its oral pyridost...

Camber
FDA Approves POMALIDOMIDE — Camber Pharmaceuticals, Inc.

# FDA Approves Generic Pomalidomide; Camber Pharmaceuticals Entry Expected to Intensify Competition Camber Pharmaceuticals, Inc. received FDA approva...